rethinkPeptides Search
Menu
Study breakdown

BPC-157 and the Revised Theory of Gut Cytoprotection: Beyond Robert's Original Concept

evidence
The takeaway

BPC-157's unique cytoprotective properties expand Robert's classical cytoprotection concept, demonstrating prostaglandin-independent protection and adaptive cytoprotection against both exogenous and endogenous irritants.

Key finding

BPC-157's unique cytoprotective properties expand Robert's classical cytoprotection concept, demonstrating prostaglandin-independent protection and ad

What the researchers found

BPC-157's unique cytoprotective properties expand Robert's classical cytoprotection concept, demonstrating prostaglandin-independent protection and adaptive cytoprotection against both exogenous and endogenous irritants.

Why it matters

Relevant for peptide research.

How the study worked

research study.

What this study cannot tell us

See abstract.

How to read the evidence

emerging evidence.

When this study was published

Published in 2010.

The bigger picture

Advances peptide research.

Questions still open

  • Further research needed.

Common questions

What was studied?
BPC-157 and the Revised Theory of Gut Cytoprotection: Beyond Robert's Original Concept
What was found?
BPC-157's unique cytoprotective properties expand Robert's classical cytoprotection concept, demonstrating prostaglandin-independent protection and adaptive cytoprotection against both exogenous and endogenous irritants.

Read the original research

Revised Robert's cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator.

Current pharmaceutical design, 16(10), 1224-34

Citation

Sikiric, Predrag; Seiwerth, Sven; Brcic, Luka; Sever, Marko; Klicek, Robert; Radic, Bozo; Drmic, Domagoj; Ilic, Spomenko; Kolenc, Danijela. (2010). Revised Robert's cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator.. Current pharmaceutical design, 16(10), 1224-34.